GabrielleYi-HuiLiuMD

Critical Care Medicine, Interstitial Lung Diseases

Assistant Professor, UC Davis School of Medicine

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

McGaw Medical Center of Northwestern UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2022
University of California (San Francisco)Residency, Internal Medicine, 2017 - 2019
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2016

PubMed

Proteomic Risk Score of Increased Respiratory Susceptibility: A Multi-Cohort Study.
Gabrielle Y Liu, Andrew S Perry, George R Washko, Eric Farber-Eger, Laura A Colangelo
American Journal of Respiratory and Critical Care Medicine. 2024-09-10
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).
Katyayini Aribindi, Gabrielle Y Liu, Timothy E Albertson
Expert Review of Clinical Pharmacology. 2024-09-01
1 citations
Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks.
Andrew S Perry, Eric Farber-Eger, Tomas Gonzales, Toshiko Tanaka, Jeremy M Robbins
Nature Medicine. 2024-06-01

Q&A: Adults May Know Their Risk for COPD with Blood TestNovember 7th, 2024
Preclinical Blood Test IDs Risk for Respiratory Death, Incident COPDSeptember 12th, 2024
Preclinical Blood Test Identifies Risk for Respiratory Death and COPD IncidentSeptember 12th, 2024
Join now to see all